Extracellular vesicles are generating excitement as tools for regenerative medicine and drug delivery — but no EV-based therapeutic has received market approval anywhere in the world. In a new Perspective article, we argue the barriers are not solely technical. They are also regulatory.

Today I’ve written a short reflection on AHPRA and the Medical Board of Australia’s (MBA) proposed options to reform the regulation of ‘late-career medical practitioners’ — ie, doctors over 70 years old — by requiring them to undergo regular health assessments. I will mostly let my short analysis published in the Conversation, speak for itself. […]

I was interviewed alongside two leading voices in plastic and cosmetic surgery on 2SER